{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/64764-304#drug","name":"Duetact","alternateName":"pioglitazone and glimepiride","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"64764-304"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA021925"},{"@type":"PropertyValue","propertyID":"UNII","value":"6KY687524K|JQT35NPK6C"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"f8b0c917-3fdd-4a28-a47d-6225b8195458"}],"activeIngredient":"GLIMEPIRIDE, PIOGLITAZONE HYDROCHLORIDE","administrationRoute":["ORAL"],"dosageForm":"TABLET","manufacturer":{"@type":"Organization","name":"Takeda Pharmaceuticals America, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA021925","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8b0c917-3fdd-4a28-a47d-6225b8195458","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64764-304"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-31T17:39:32.461Z"}}